Conservative treatment of femoral neuropathy following retroperitoneal hemorrhage: a case report and review of literature.

Abstract

Anticoagulant drugs are used to reduce the incidence of thromboembolic events in patients at risk. However, minor and major bleeding complications may occur during anticoagulation therapy. Femoral neuropathy secondary to retroperitoneal hematoma is a well known complication of anticoagulant drugs. However, treatment of these patients is still controversial, both conservative and surgical treatments have been advocated. Herein, we report a male patient receiving warfarin for 7 years who developed femoral neuropathy due to retroperitoneal hematoma and was successfully treated with conservative methods. We suggest that conservative treatment and appropriate rehabilitation program should be given to the patients who do not demonstrate any signs of a continued bleeding and any progressive neurological deficits.

• Authors: Aliye Tosun, Elem İnal, Işk Keleş, Murat Tulmaç, Özgür Tosun, Gülümser Aydın, Sevim Orkun
• Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 25 Issue 7 Pg. 769-72 (Oct 2014) ISSN: 1473-5733 [Electronic] England
• PMID: 24686104 (Publication Type: Case Reports, Journal Article, Review)

Chemical References

• Anticoagulants
• Warfarin

Topics

• Adult
• Anticoagulants (adverse effects, therapeutic use)
• Femoral Neuropathy (etiology, therapy)
• Hematoma (chemically induced, complications)
• Humans
• Male
• Retroperitoneal Space (blood supply)
• Risk Factors
• Thromboembolism (drug therapy)
• Treatment Outcome
• Warfarin (adverse effects, therapeutic use)
• Young Adult